InMed Pharmaceuticals Inc. (INM)

Last Closing Price: 2.11 (2025-10-13)

Receiveable Turnover (Quarterly)

Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable

InMed Pharmaceuticals Inc. (INM) had Receiveable Turnover of 2.81 for the most recently reported fiscal quarter, ending 2025-06-30.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
$1.30M
$-1.79M
$0.73M
$0.58M
$3.15M
$-1.84M
$0.05M
$-1.79M
$-1.79M
$-1.79M
$-1.79M
$-1.79M
$-1.79M
$-1.84M
$-1.79M
0.98M
0.98M
$51.42
$51.42
Balance Sheet Financials
$12.87M
$0.99M
$2.71M
$15.58M
$1.84M
$0.31M
$0.31M
$2.15M
$13.43M
$11.81M
$13.43M
2.00M
Cash Flow Statement Financials
$-7.77M
--
$12.27M
$6.57M
$11.08M
$4.50M
$0.12M
--
--
Fundamental Metrics & Ratios
6.99
--
--
0.02
0.06
44.20%
-141.19%
-141.19%
--
-137.07%
-137.07%
$-7.77M
--
--
--
0.08
0.76
Receiveable Turnover
2.81
32.08
-13.31%
-15.14%
-11.48%
-13.02%
$6.71
$-7.96
$-7.96